Nanoligent has been selected for pitching next May 5th in the Oncology Upward Investment session of the 6th edition of the MEET2WIN European Oncology Partnering Convention. MEET2WIN is an European Partnering Convention fully dedicated to open innovation in oncology. For 2 days, the congress will host conferences, project pitches, one-to-one business meetings and an exhibition area. A quick pitch presentation of Nanoligent will also be available on-line for all the assistants.
Bioengineering and Medtech against Cancer
noviembre 11, 2020
